Balance Naturopathic Health Centre

The shortest way to do many things is to do only one thing at a time. — Richard Cech

News

Bill C-51 Info

June 5th, 2008

What is Bill C-51?

Federal legislation tabled on April 8, 2008. It proposes significant amendments to the Food and Drugs Act. The bill received second reading on April 30, 2008 and debate continues. Once debate is concluded there will be a vote on the motion to move the bill to the Standing Committee on Health. It is expected that all parties will support the motion. During the hearings before the Standing Committee on Health stakeholders and M.P.'s on the committee will have the opportunity to express their concerns and propose amendments to Bill C -51.

What does Bill C-51 Do? What are the CAND's Concerns?

It moves natural health products, medical devices, cells, tissues, organs and drugs under the heading "therapeutic products". It does not differentiate between drugs and natural health products. At this point the bill does not impact the Natural Health Product Regulations.

It defines a practitioner in such a manner that NDs will be denied access to natural health products deemed prescription therapeutic products. It also includes definitions of "sell" and "controlled activity" that differ from provincial legislation.

It proposes sweeping new powers of enforcement with increased penalties including the ability to enter business establishments without a warrant.

What is the CAND doing?

  • Developed templates for members to use in expressing their concerns to their Members of Parliament.
  • Engaging in dialogue with other stakeholders to develop strategies for collaboration.
  • Engaging in discussions with key government officials to make sure our voice is heard on how the bill impacts NDs and expressing our support for a third category for natural health products.
  • Preparing a Brief to the Standing Committee on Health.

What can NDs Do?

  • Contact the CAND with any questions or concerns.
  • Use the CAND letter templates to contact your MP and express your concerns.
  • Stay tuned for further updates from the CAND.

Related